Candesant recently raised $35m USD to advance commercialisation, not going into distribution until early 2024, significantly later than they planned once FDA approval was given in April this year. So either they weren't prepped with a sales/marketing plan or that plan has not been able to be executed and they've had to do a sizeable raise to grow distribution.
Finally, after a quick trawl on instagram there are a ton of 'Disallowed' hyperhidrosis products out there, something BOT will need to cut through to drive penetration into the marketplace.
Candesant recently raised $35m USD to advance commercialisation,...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.005(2.04%) |
Mkt cap ! $393.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.5¢ | 24.5¢ | $823.6K | 3.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 292257 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 67065 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
0.005 ( 3.22 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 25.5¢ | 24.5¢ | 1596484 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| BOT (ASX) Chart |